BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 18673195)

  • 1. Clinical drugs that interact with St. John's wort and implication in drug development.
    Di YM; Li CG; Xue CC; Zhou SF
    Curr Pharm Des; 2008; 14(17):1723-42. PubMed ID: 18673195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic interactions of drugs with St John's wort.
    Zhou S; Chan E; Pan SQ; Huang M; Lee EJ
    J Psychopharmacol; 2004 Jun; 18(2):262-76. PubMed ID: 15260917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug interactions with St. John's Wort (Hypericum perforatum): a review of the clinical evidence.
    Izzo AA
    Int J Clin Pharmacol Ther; 2004 Mar; 42(3):139-48. PubMed ID: 15049433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An update on clinical drug interactions with the herbal antidepressant St. John's wort.
    Zhou SF; Lai X
    Curr Drug Metab; 2008 Jun; 9(5):394-409. PubMed ID: 18537576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between herbal medicines and prescribed drugs: an updated systematic review.
    Izzo AA; Ernst E
    Drugs; 2009; 69(13):1777-98. PubMed ID: 19719333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical risks of St John's Wort (Hypericum perforatum) co-administration.
    Soleymani S; Bahramsoltani R; Rahimi R; Abdollahi M
    Expert Opin Drug Metab Toxicol; 2017 Oct; 13(10):1047-1062. PubMed ID: 28885074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical herbal interactions with conventional drugs: from molecules to maladies.
    Chen XW; Serag ES; Sneed KB; Liang J; Chew H; Pan SY; Zhou SF
    Curr Med Chem; 2011; 18(31):4836-50. PubMed ID: 21919844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperforin in St. John's wort drug interactions.
    Madabushi R; Frank B; Drewelow B; Derendorf H; Butterweck V
    Eur J Clin Pharmacol; 2006 Mar; 62(3):225-33. PubMed ID: 16477470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance of in vitro and clinical data for predicting CYP3A4-mediated herb-drug interactions in cancer patients.
    Goey AK; Mooiman KD; Beijnen JH; Schellens JH; Meijerman I
    Cancer Treat Rev; 2013 Nov; 39(7):773-83. PubMed ID: 23394826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of St. John's wort drug interactions revisited.
    Nicolussi S; Drewe J; Butterweck V; Meyer Zu Schwabedissen HE
    Br J Pharmacol; 2020 Mar; 177(6):1212-1226. PubMed ID: 31742659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herb-drug interactions and mechanistic and clinical considerations.
    Chen XW; Sneed KB; Pan SY; Cao C; Kanwar JR; Chew H; Zhou SF
    Curr Drug Metab; 2012 Jun; 13(5):640-51. PubMed ID: 22292789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-herb interactions: eliminating toxicity with hard drug design.
    Yang XX; Hu ZP; Duan W; Zhu YZ; Zhou SF
    Curr Pharm Des; 2006; 12(35):4649-64. PubMed ID: 17168768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emerging recognition of herb-drug interactions with a focus on St. John's wort (Hypericum perforatum).
    Markowitz JS; DeVane CL
    Psychopharmacol Bull; 2001; 35(1):53-64. PubMed ID: 12397870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDR- and CYP3A4-mediated drug-herbal interactions.
    Pal D; Mitra AK
    Life Sci; 2006 Mar; 78(18):2131-45. PubMed ID: 16442130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug interactions with St John's wort : mechanisms and clinical implications.
    Mannel M
    Drug Saf; 2004; 27(11):773-97. PubMed ID: 15350151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-administration of St. John's wort and hormonal contraceptives: a systematic review.
    Berry-Bibee EN; Kim MJ; Tepper NK; Riley HE; Curtis KM
    Contraception; 2016 Dec; 94(6):668-677. PubMed ID: 27444983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.
    Borrelli F; Izzo AA
    AAPS J; 2009 Dec; 11(4):710-27. PubMed ID: 19859815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herb-drug interactions: a literature review.
    Hu Z; Yang X; Ho PC; Chan SY; Heng PW; Chan E; Duan W; Koh HL; Zhou S
    Drugs; 2005; 65(9):1239-82. PubMed ID: 15916450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. St John's wort (Hypericum perforatum): drug interactions and clinical outcomes.
    Henderson L; Yue QY; Bergquist C; Gerden B; Arlett P
    Br J Clin Pharmacol; 2002 Oct; 54(4):349-56. PubMed ID: 12392581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No relevant interaction with alprazolam, caffeine, tolbutamide, and digoxin by treatment with a low-hyperforin St John's wort extract.
    Arold G; Donath F; Maurer A; Diefenbach K; Bauer S; Henneicke-von Zepelin HH; Friede M; Roots I
    Planta Med; 2005 Apr; 71(4):331-7. PubMed ID: 15856409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.